Advanced Search

Nrs: Chapter 454 - Poisons; Dangerous Drugs And Hypodermics


Published: 2015

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now for only USD$40 per month.
[Rev. 2/10/2015 5:35:46

PM--2014R2]

CHAPTER 454 - POISONS; DANGEROUS DRUGS AND

HYPODERMICS

GENERAL PROVISIONS

NRS 454.001           Definitions.



NRS 454.0015         “Advanced

practice registered nurse” defined.

NRS 454.002           “Authorized

officers of the law” defined.

NRS 454.003           “Board”

defined.

NRS 454.0041         “Chart

order” defined.

NRS 454.005           “Chemical”

defined.

NRS 454.0053         “Compound”

and “compounding” defined.

NRS 454.0058         “Fill”

defined.

NRS 454.006           “Furnish”

defined.

NRS 454.007           “Hospital”

defined.

NRS 454.009           “Hypodermics”

defined.

NRS 454.00905       “Institutional

pharmacy” defined.

NRS 454.00911       “Laboratory”

defined.

NRS 454.0092         “Manufacturer”

defined.

NRS 454.00922       “Medical

intern” defined.

NRS 454.0094         “Pharmacy”

defined.

NRS 454.00945       “Pharmacy

in a correctional institution” defined.

NRS 454.0095         “Physician,”

“dentist,” “podiatric physician,” “optometrist,” “veterinarian” and

“pharmacist” defined.

NRS 454.00958       “Practitioner”

defined.

NRS 454.00961       “Prescription”

defined.

NRS 454.00973       “Public

health program” defined.

NRS 454.00976       “Refill”

defined.

NRS 454.00978       “Ultimate

user” defined.

NRS 454.0098         “Wholesaler”

defined.

POISONS

Definitions

NRS 454.010           “Poison”

defined.

 

Regulation of Sale

NRS 454.020           Poisons

enumerated in Schedules “A,” “B” and “C” in NRS 454.010

may not be sold unless warning label affixed to package.

NRS 454.030           Requirements

for sale or delivery of poison listed in Schedule “A” or “B.”

NRS 454.040           Fictitious

name or false representations to seller or dealer prohibited.

NRS 454.045           Sale

or delivery of poison listed in Schedule “B” only by registered pharmacist.

NRS 454.050           Book

of transactions concerning poison: Contents; when entry required; exceptions.

NRS 454.060           Book

of transactions concerning poison: Form and preservation.

NRS 454.080           English

language to be used in book and on label or package; additional entry in

foreign language permissible.

NRS 454.090           Sale

of poison listed in Schedule “A” exempt from registration.

 

Administration

NRS 454.110           Additional

restrictions on sale of poison; adoption of regulations by Board.

NRS 454.130           Telephone

number of poison control center to be available at pharmacies.

NRS 454.150           Agents

for enforcement; access for inspection.

NRS 454.160           District

attorney to conduct actions and prosecutions.

NRS 454.170           Penalty.

DANGEROUS DRUGS AND HYPODERMIC DEVICES

Dangerous Drugs

NRS 454.181           Application

of definitions.

NRS 454.191           “Administer”

defined.

NRS 454.201           “Dangerous

drug” defined.

NRS 454.211           “Dispense”

defined.

NRS 454.213           Authority

to possess and administer dangerous drug.

NRS 454.215           Authority

to dispense dangerous drug.

NRS 454.221           Furnishing

dangerous drug without prescription prohibited; penalty; exceptions.

NRS 454.223           Prescription

to be written on prescription blank or chart of patient; contents; regulations.

NRS 454.231           Pharmacist

to fill or refill prescription for use only by person to whom prescription

originally issued.

NRS 454.286           Records:

Maintenance; retention; inspection; penalty.

NRS 454.291           Stock

of dangerous drugs and records open to inspection; penalty.

NRS 454.296           Immunity

from prosecution of employees of Board and peace officers.

NRS 454.301           Conditions

under which practitioner or veterinarian may furnish drugs without

prescription.

NRS 454.303           Certain

school employees authorized to administer auto-injectable epinephrine.

NRS 454.306           Use

of minor as agent; unlawful furnishing of dangerous drug to minor; penalty.

NRS 454.311           Fraudulent

possession of dangerous drug or prescription; false or altered prescription;

penalty.

NRS 454.316           Possession

of dangerous drug without prescription unlawful; penalties; exceptions.

NRS 454.321           Unlawful

dispensing or furnishing of dangerous drug; penalty.

NRS 454.323           Sale

or distribution of product containing toluene to person less than 18 years of

age.

NRS 454.326           Misrepresentation

by use of telephone to obtain dangerous drug; penalty.

NRS 454.341           Unlawful

possession or sale of nasal inhaler; exception.

NRS 454.346           Use

or possession with intent to use drug, chemical, poison or organic solvent to

induce euphoria or hallucinations unlawful; exception.

NRS 454.351           Drugs

which may not be introduced into interstate commerce; penalty; exemptions.

NRS 454.356           Penalty

for violation.

NRS 454.358           Fee

for analysis of dangerous drug included in sentence; distribution of money

collected; limitations on use of money.

NRS 454.361           Conviction

for violation of provision concerning dangerous drugs constitutes grounds for

suspension or revocation of professional license.

NRS 454.366           Administration

and enforcement by Board.

NRS 454.371           Limitations

on furnishing dangerous drug; adoption of regulations by Board; penalties.

 

Hypodermic Devices

NRS 454.480           Requirements

for sale with or without prescription.

NRS 454.500           Regulation

of sale of hypodermic devices other than hypodermic needles or syringes.

NRS 454.510           Unlawful

possession of hypodermic device.

NRS 454.520           Misuse

of hypodermic device; penalty. [Repealed.]

NRS 454.530           Obtaining

possession of hypodermic device by forged or fictitious name or fraudulent

misrepresentation; penalty.

 

Enforcement

NRS 454.534           Burden

of proving exception or exemption.

NRS 454.535           Amount

of drug needed to sustain conviction for prohibited offense.

MISCELLANEOUS PROVISIONS

NRS 454.680           Applicability

to certain products.

NRS 454.695           Prescriptions

by advanced practice registered nurses.

NRS 454.710           Injunctions.

_________

_________

 

GENERAL PROVISIONS

      NRS 454.001  Definitions.  As

used in this chapter, the words and terms defined in NRS

454.0015 to 454.0098, inclusive, have the

meanings ascribed to them in those sections, unless a different meaning clearly

appears in the context.

      (Added to NRS by 1967, 1635; A 1977, 187; 1979, 1674; 1987, 952, 1656; 1991, 794, 1955)

      NRS 454.0015  “Advanced practice registered nurse” defined.  “Advanced practice registered nurse” means a

registered nurse who holds a valid license as an advanced practice registered

nurse issued by the State Board of Nursing pursuant to NRS 632.237.

      (Added to NRS by 1991, 794; A 2013, 2087)

      NRS 454.002  “Authorized officers of the law” defined.  “Authorized officers of the law” means:

      1.  Peace officers;

      2.  Members, investigators and inspectors

of the Board;

      3.  Inspectors of the Food and Drug

Administration; and

      4.  Commissioners and agents appointed as

provided in chapter 585 of NRS for the

enforcement of the Nevada Food, Drug and Cosmetic Act.

      (Added to NRS by 1967, 1635)

      NRS 454.003  “Board” defined.  “Board”

means the State Board of Pharmacy.

      (Added to NRS by 1967, 1635)

      NRS 454.0041  “Chart order” defined.  “Chart

order” means an order entered on the chart of a patient:

      1.  In a hospital, facility for

intermediate care or facility for skilled nursing which is licensed as such by

the Division of Public and Behavioral Health of the Department of Health and

Human Services; or

      2.  Under emergency treatment in a hospital

by a practitioner or on the written or oral order of a practitioner authorizing

the administration of a drug to the patient.

      (Added to NRS by 1973, 1196; A 1979, 1674; 1985, 1751)

      NRS 454.005  “Chemical” defined.  “Chemical”

includes all chemicals intended, designed and labeled for use in the cure,

treatment, mitigation or prevention of disease in humans or other animals.

      (Added to NRS by 1967, 1635)

      NRS 454.0053  “Compound” and “compounding” defined.  “Compound”

or “compounding” means to form or make up a composite product by combining two

or more different ingredients.

      (Added to NRS by 1979, 1681)

      NRS 454.0058  “Fill” defined.  “Fill”

means the counting, measuring, compounding, pouring, packaging and labeling

required to prepare a drug for either direct or indirect delivery to a patient.

      (Added to NRS by 1979, 1681)

      NRS 454.006  “Furnish” defined.  “Furnish”

means to supply by any means, by sale or otherwise.

      (Added to NRS by 1967, 1635)

      NRS 454.007  “Hospital” defined.  “Hospital”

means any institution, place, building or agency which is licensed by the

Department of Health and Human Services as a hospital and which operates

facilities for the care and treatment of human illness or other abnormal

physical or mental conditions on an inpatient basis, including any such

facility operated by this State or a political subdivision of this State.

      (Added to NRS by 1967, 1635; A 1979, 1674; 1987, 952)

      NRS 454.009  “Hypodermics” defined.  “Hypodermics”

means any syringe, needle, instrument, device or implement intended or capable

of being adapted for the purpose of administering drugs by subcutaneous,

intramuscular or intravenous injection.

      (Added to NRS by 1967, 1635)

      NRS 454.00905  “Institutional pharmacy” defined.  “Institutional

pharmacy” means a pharmacy or other storage place as defined by regulations

adopted by the Board which is a part of or is operated in conjunction with a

medical facility as that term is defined in NRS

449.0151. The term includes:

      1.  A pharmacy on the premises of the

medical facility which provides a system of distributing and supplying

medication to the facility, whether or not operated by the facility; and

      2.  A pharmacy off the premises of the

medical facility which provides services only to the patients of the facility

and provides a system of distributing medication based upon chart orders from

the medical facility.

      (Added to NRS by 1987, 1656; A 1993, 1990)

      NRS 454.00911  “Laboratory” defined.  “Laboratory”

means a research, teaching or testing laboratory not engaged in the sale of

drugs but using dangerous drugs for scientific or teaching purposes.

      (Added to NRS by 1973, 1196)

      NRS 454.0092  “Manufacturer” defined.  “Manufacturer”

means a person who:

      1.  Derives, produces, prepares, compounds,

mixes, cultivates, grows or processes any drug;

      2.  Repackages any drug for the purpose of

resale; or

      3.  Makes, produces or prepares any devices

or appliances that are restricted by federal law to sale by or on the order of

a physician.

      (Added to NRS by 1967, 1635; A 1971, 2028; 1973,

1195; 1993, 636,

1223)

      NRS 454.00922  “Medical intern” defined.  “Medical

intern” means a medical graduate acting as an assistant in a hospital for the

purpose of clinical training.

      (Added to NRS by 1981, 746)

      NRS 454.0094  “Pharmacy” defined.

      1.  “Pharmacy” means every store or shop

licensed by the Board where drugs, controlled substances, poisons, medicines or

chemicals are stored or possessed, or dispensed or sold at retail, or displayed

for sale at retail, or where prescriptions are compounded or dispensed.

      2.  “Pharmacy” includes pharmacies owned or

operated by the State of Nevada and political subdivisions and municipal

corporations therein.

      (Added to NRS by 1967, 1636; A 1971, 2028; 1973,

1196; 1979,

1674)

      NRS 454.00945  “Pharmacy in a correctional institution” defined.  “Pharmacy in a correctional institution” means

a pharmacy or other storage place for medicines, controlled substances and

dangerous drugs which is a part of or is operated in conjunction with a

correctional facility, including a jail and facility for the detention of

juveniles.

      (Added to NRS by 1987, 1656)

      NRS 454.0095  “Physician,” “dentist,” “podiatric physician,” “optometrist,”

“veterinarian” and “pharmacist” defined.  “Physician,”

“dentist,” “podiatric physician,” “optometrist,” “veterinarian” and

“pharmacist” mean persons authorized by a currently valid license to practice

their respective professions in this State.

      (Added to NRS by 1967, 1636; A 1969, 347; 1977, 964; 1993, 2236; 1995, 1034)

      NRS 454.00958  “Practitioner” defined.  “Practitioner”

means:

      1.  A physician, dentist, veterinarian or

podiatric physician who holds a valid license to practice his or her profession

in this State.

      2.  A pharmacy, hospital or other

institution licensed or registered to distribute, dispense, conduct research

with respect to or to administer a dangerous drug in the course of professional

practice in this State.

      3.  When relating to the prescription of

poisons, dangerous drugs and devices:

      (a) An advanced practice registered nurse who

holds a certificate from the State Board of Pharmacy permitting him or her so

to prescribe; or

      (b) A physician assistant who holds a license

from the Board of Medical Examiners and a certificate from the State Board of

Pharmacy permitting him or her so to prescribe.

      4.  An optometrist who is certified to

prescribe and administer dangerous drugs pursuant to NRS 636.288 when the optometrist

prescribes or administers dangerous drugs which are within the scope of his or

her certification.

      (Added to NRS by 1979, 1681; A 1983, 1220; 1989, 1995; 1991, 794; 1993, 2236; 1995, 1034; 2001, 788; 2013, 2088)

      NRS 454.00961  “Prescription” defined.

      1.  “Prescription” means:

      (a) An order given individually for the person

for whom prescribed, directly from the practitioner, or the practitioner’s

agent, to a pharmacist or indirectly by means of an order signed by the practitioner

or an electronic transmission from the practitioner to a pharmacist.

      (b) A chart order written for an inpatient

specifying drugs which he or she is to take home upon discharge.

      2.  “Prescription” does not include a chart

order written for an inpatient for use while he or she is an inpatient.

      (Added to NRS by 1973, 1196; A 1979, 1675; 1983, 1515; 1987, 1657; 1991, 1956)

      NRS 454.00973  “Public health program” defined.  “Public

health program” means a program of the government which is:

      1.  Administered by the officers and agents

of:

      (a) The Division of Public and Behavioral Health

of the Department of Health and Human Services; or

      (b) The local boards of health; and

      2.  Created to serve the health needs of an

entire political subdivision by reducing the incidence and prevalence of a

disease, subset of disease or a medical event.

      (Added to NRS by 1991, 1955; A 1995, 556)

      NRS 454.00976  “Refill” defined.  “Refill”

means to fill again.

      (Added to NRS by 1979, 1681)

      NRS 454.00978  “Ultimate user” defined.  “Ultimate

user” means a person who lawfully possesses a dangerous drug for the person’s

own use or the use of a member of the person’s household or for administering

to any animal owned by the person or by a member of the person’s household. The

term includes the guardian of an ultimate user or any other person authorized

in a durable power of attorney to act on the behalf of the ultimate user. The

term does not include a patient in or an employee of a medical facility, as

defined in NRS 449.0151, who is not

statutorily authorized to administer drugs.

      (Added to NRS by 1987, 952; A 1993, 1216; 1995, 556)

      NRS 454.0098  “Wholesaler” defined.  “Wholesaler”

means a wholesale distributor as defined by 21 C.F.R. § 205.3(g) who supplies

dangerous drugs or chemicals or devices or appliances that are restricted by

federal law to sale by or on the order of a physician to a person other than

the consumer or patient. The term does not include:

      1.  A person who derives, produces or

prepares medicines, chemicals or devices on sales orders for resale.

      2.  A nonprofit cooperative agricultural

organization which supplies or distributes veterinary drugs and medicines only

to its own members.

      (Added to NRS by 1967, 1636; A 1971, 2028; 1973,

1196; 1991,

1164; 1993,

1223)

POISONS

Definitions

      NRS 454.010  “Poison” defined.  As

used in NRS 454.010 to 454.170,

inclusive, “poison” means any substance having an inherent deleterious property

which when internally or externally applied to the body of a human or animal is

capable of causing damage to the tissues, destroying the action of vital

functions of the body or causing death, and includes the compositions of the

following schedules:

 

      Schedule “A”:

      1.  Aconite, belladonna, cantharadis and

nux vomica.

      2.  Alkaloids and derivatives.

      3.  Antiseptic tablets containing corrosive

sublimate.

      4.  Arsenic, its compounds and

preparations.

      5.  Corrosive sublimate.

      6.  Cyanide of potassium.

      7.  Hydrocyanic acid.

      8.  Oils of croton.

      9.  Phosphorus and its poisonous

derivatives or compounds.

      10.  Rue and tansy.

      11.  Sodium fluoracetate and preparations.

      12.  Strophanthus or its

preparations.

      13.  Strychnine.

      14.  Zinc phosphide and preparations.

      15.  All compounds, preparations or

products, other than cosmetics, which contain any of the following poisons as

the primary solvent or in amounts capable of causing intoxication or harmful

physical effects if inhaled, absorbed or ingested:

      (a) Ethyl acetate.

      (b) Isobutyl ketone.

      (c) Methyl cellulose acetate.

      (d) Methyl ethyl ketone.

      (e) Trichlorethylene.

 

      Schedule “B”:

      1.  Bromides.

      2.  Chloroform.

      3.  Cocculus indicus or its

preparations.

      4.  Cowhage.

      5.  Creosote.

      6.  Ether.

      7.  Hydrochloric or muriatic acid.

      8.  Nitric acid.

      9.  Oils of savin and pennyroyal.

      10.  Oxalic acid.

      11.  Solution of formaldehyde or formalin.

      12.  Sugar of lead.

      13.  Sulfate of zinc.

      14.  Sulfuric acid.

      15.  Tartar emetic and other derivatives of

antimony.

      16.  Veratrum.

      17.  Wood alcohol or methanol.

 

      Schedule “C”:

      1.  Carbon tetrachloride or any preparation

in which it is used as the primary solvent.

      2.  Any preparation or substance which

contains any of the poisons listed in Schedule “A” or “B” in amounts capable of

causing harmful physical effects if inhaled, absorbed or ingested, when such

products or preparations are intended and designed for agricultural,

commercial, economic, industrial or household use, and are labeled in

compliance with the provisions of NRS 454.020 and 454.080.

      [Part 7:207:1913; A 1921, 66; NCL § 5081]—(NRS A

1959, 66; 1967, 1627; 1993, 636)

Regulation of Sale

      NRS 454.020  Poisons enumerated in Schedules “A,” “B” and “C” in NRS

454.010 may not be sold unless warning label affixed to package.

      1.  It is unlawful for any person to vend,

sell, give away or furnish, either directly or indirectly, any poisons

enumerated in Schedules “A,” “B” and “C” in NRS 454.010

without labeling the container, package, box, bottle or paper in which the

poison is contained with:

      (a) The name of the article.

      (b) The word “poison,” which shall be printed in

boldface type in capital letters not less than twice the size of other type on

the label.

      (c) The name and place of business of the person

or firm manufacturing or selling the poison.

      (d) The vignette representing the skull and

crossbones.

      (e) The first aid treatment or antidote approved

by the Board or the American Chemical Manufacturers Association for such

poison.

      (f) Any supplemental warnings or cautions

required by either state or federal law or by regulations of the Board.

      2.  The label shall be printed in type that

can be clearly read, upon red paper in distinct white letters or in distinct

red letters upon white paper.

      [Part 1:207:1913; 1919 RL p. 2882; NCL § 5075]—(NRS A

1959, 67; 1967, 1628)

      NRS 454.030  Requirements for sale or delivery of poison listed in Schedule

“A” or “B.”  It is unlawful to

vend, sell, deliver or otherwise furnish any of the poisons named in Schedule

“A” or “B” or any other dangerously poisonous drug, chemical or medical

substance which may from time to time be designated by the Board, unless on

inquiry it is found that the person desiring the same is 18 years of age or

older and is aware of its poisonous character, and it satisfactorily appears

that it is to be used for a legitimate purpose.

      [Part 1:207:1913; 1919 RL p. 2882; NCL § 5075]—(NRS A

1967, 1629)

      NRS 454.040  Fictitious name or false representations to seller or dealer

prohibited.  It is unlawful for any

person to give a fictitious name or false address or make any false

representations to the seller or dealer when buying any of the poisons

enumerated in Schedule “A” or the additions thereto.

      [Part 1:207:1913; 1919 RL p. 2882; NCL § 5075]—(NRS A

1967, 1629)

      NRS 454.045  Sale or delivery of poison listed in Schedule “B” only by

registered pharmacist.  It is

unlawful for any person, other than a registered pharmacist or an intern

pharmacist acting under the direct and immediate supervision of a registered

pharmacist, to vend, sell, furnish or deliver any poison enumerated in Schedule

“B” of NRS 454.010.

      (Added to NRS by 1967, 1636; A 1971, 682)

      NRS 454.050  Book of transactions concerning poison: Contents; when entry

required; exceptions.

      1.  It is unlawful to vend, sell, furnish

or deliver any poison included in Schedule “A,” the additions thereto or those

enumerated by regulation of the Board without making or causing to be made, at

the time of the sale, an entry in a book kept solely for that purpose, stating:

      (a) The date of sale.

      (b) The name, complete residence or business

address and signature of the purchaser.

      (c) The name and quantity of the poison sold.

      (d) The statement by the purchaser of the purpose

for which the poison is required.

      (e) The signature of the dispenser, who must be a

registered pharmacist or a registered intern pharmacist acting under the direct

and immediate supervision of a registered pharmacist.

      2.  The provisions of this section do not

apply when the poisons enumerated in Schedule “A” are used as solvents for

glues and cements used in making of models, when sold in single units or

containers simultaneously with or as a part of a kit to be used for the

construction of model airplanes, boats, automobiles, trains or other similar

models if such kits have been assembled by a recognized manufacturer of such

kits and are advertised as such.

      [Part 1:207:1913; 1919 RL p. 2882; NCL § 5075]—(NRS A

1967, 1629; 1971, 682; 1977, 74)

      NRS 454.060  Book of transactions concerning poison: Form and preservation.

      1.  The poison book shall be in form

substantially as follows:

 



                 Name of                              Kind

and        Purpose          Signature of       Signature of

   Date       Purchaser       Residence       Quantity          of

Use            Pharmacist          Purchaser



 

      2.  This book shall always be open for

inspection by authorized officers of the law acting in their official capacity,

and shall be preserved for at least 5 years after the date of the last entry

therein.

      [Part 1:207:1913; 1919 RL p. 2882; NCL § 5075]—(NRS A

1967, 1630)

      NRS 454.080  English language to be used in book and on label or package;

additional entry in foreign language permissible.  The

entries in the poison book and the printed or written matter required to be

placed on the label or the package shall be in the English language, except

that the vendor of the poison may enter the same in any foreign language the

vendor may desire, in addition to the entry and label in English.

      [Part 3:207:1913; 1919 RL p. 2883; NCL § 5077]

      NRS 454.090  Sale of poison listed in Schedule “A” exempt from registration.

      1.  Dealers, manufacturers and pharmacists

are exempted from the registration of the sale of any poison enumerated in

Schedule “A” or the additions thereto when sold:

      (a) To a registered pharmacist or a practitioner;

      (b) To a manufacturer or wholesaler;

      (c) To a research, teaching or testing

laboratory; or

      (d) To other established, legitimate users in

chemical or technical arts.

      2.  The provisions of NRS 454.010 to 454.170,

inclusive, shall not apply to the sale of any poison upon the prescriptions of

practitioners.

      [Part 5:207:1913; 1919 RL p. 2883; NCL § 5079]—(NRS A

1967, 1630; 1969, 902; 1979, 1675)

Administration

      NRS 454.110  Additional restrictions on sale of poison; adoption of

regulations by Board.  When, in the

opinion of the Board, it is in the interest of the public health, the Board is

empowered to restrict or prohibit further the retail sale of any poison by regulations

not inconsistent with the provisions of NRS 454.010

to 454.170, inclusive. Such regulations may be

adopted by the Board and must be applicable to all persons alike.

      [Part 4:207:1913; 1919 RL p. 2883; NCL § 5078]—(NRS A

1979, 1675)

      NRS 454.130  Telephone number of poison control center to be available at

pharmacies.  Each pharmacy must

have available for the information of the public the telephone number of the

closest poison control center.

      [Part 1:207:1913; 1919 RL p. 2882; NCL § 5075]—(NRS A

1981, 746)

      NRS 454.150  Agents for enforcement; access for inspection.  The Commissioner and agents appointed as

provided in chapter 585 of NRS for the

enforcement of the Nevada Food, Drug and Cosmetic Act are designated and

constituted agents for the enforcement of NRS 454.010

to 454.170, inclusive, and shall cooperate with the

Board in carrying out the provisions of NRS 454.010

to 454.170, inclusive. For this purpose, they shall

have free access at all times during business hours to all places where drugs,

medicines or poisons are offered for sale.

      [9:207:1913; 1919 RL p. 2886; NCL § 5083]—(NRS A

1967, 1631)

      NRS 454.160  District attorney to conduct actions and prosecutions.  The district attorney of the county wherein

any violation of NRS 454.010 to 454.170, inclusive, is committed shall conduct all

actions and prosecutions for the same at the request of the Board.

      [Part 6:207:1913; A 1915, 119; 1919 RL p. 2883; NCL §

5080]—(NRS A 1967, 1631)

      NRS 454.170  Penalty.  Any person

violating any of the provisions of NRS 454.010 to 454.160, inclusive, shall be guilty of a misdemeanor.

      [Part 7:207:1913; A 1921, 66; NCL § 5081]—(NRS A

1967, 586)

DANGEROUS DRUGS AND HYPODERMIC DEVICES

Dangerous Drugs

      NRS 454.181  Application of definitions.  Definitions

of words and terms in NRS 454.00922, 454.191, 454.201 and 454.211 apply only to NRS

454.181 to 454.371, inclusive.

      (Added to NRS by 1973, 1196; A 1981, 746; 1987, 1399)

      NRS 454.191  “Administer” defined.  “Administer”

means the direct application of a drug or medicine referred to in NRS 454.181 to 454.371,

inclusive, whether by injection, inhalation, ingestion or any other means, to

the body of a patient or research subject.

      (Added to NRS by 1973, 1196; A 1977, 672, 964; 1979, 593, 1676)

      NRS 454.201  “Dangerous drug” defined.  “Dangerous

drug” means any drug, other than a controlled substance, unsafe for

self-medication or unsupervised use, and includes the following:

      1.  Any drug which has been approved by the

Food and Drug Administration for general distribution and bears the legend:

“Caution: Federal law prohibits dispensing without prescription”;

      2.  Procaine hydrochloride with

preservatives and stabilizers (Gerovital H3) in injectable doses and amygdalin

(laetrile) which have been licensed by the State Board of Health for

manufacture in this State but have not been approved as drugs by the Food and

Drug Administration; or

      3.  Any drug which, pursuant to the Board’s

regulations, may be sold only by prescription because the Board has found those

drugs to be dangerous to public health or safety.

      (Added to NRS by 1973, 1197; A 1977, 1645; 1983, 336; 1987, 1553)

      NRS 454.211  “Dispense” defined.

      1.  “Dispense” means the furnishing of a

dangerous drug in any amount greater than that which is necessary for the

present and immediate needs of the ultimate user.

      2.  The term does not include the furnishing

of a dangerous drug by a hospital pharmacy for inpatients.

      (Added to NRS by 1973, 1197; A 1977, 673; 1979, 594, 1676; 1987, 1657)

      NRS 454.213  Authority to possess and administer dangerous drug.  A drug or medicine referred to in NRS 454.181 to 454.371,

inclusive, may be possessed and administered by:

      1.  A practitioner.

      2.  A physician assistant licensed pursuant

to chapter 630 or 633 of NRS, at the direction of his or her

supervising physician or a licensed dental hygienist acting in the office of

and under the supervision of a dentist.

      3.  Except as otherwise provided in

subsection 4, a registered nurse licensed to practice professional nursing or

licensed practical nurse, at the direction of a prescribing physician,

physician assistant licensed pursuant to chapter

630 or 633 of NRS, dentist, podiatric

physician or advanced practice registered nurse, or pursuant to a chart order,

for administration to a patient at another location.

      4.  In accordance with applicable

regulations of the Board, a registered nurse licensed to practice professional

nursing or licensed practical nurse who is:

      (a) Employed by a health care agency or health

care facility that is authorized to provide emergency care, or to respond to

the immediate needs of a patient, in the residence of the patient; and

      (b) Acting under the direction of the medical

director of that agency or facility who works in this State.

      5.  A medication aide - certified at a

designated facility under the supervision of an advanced practice registered

nurse or registered nurse and in accordance with standard protocols developed

by the State Board of Nursing. As used in this subsection, “designated

facility” has the meaning ascribed to it in NRS

632.0145.

      6.  Except as otherwise provided in

subsection 7, an advanced emergency medical technician or a paramedic, as

authorized by regulation of the State Board of Pharmacy and in accordance with

any applicable regulations of:

      (a) The State Board of Health in a county whose

population is less than 100,000;

      (b) A county board of health in a county whose

population is 100,000 or more; or

      (c) A district board of health created pursuant

to NRS 439.362 or 439.370 in any county.

      7.  An advanced emergency medical

technician or a paramedic who holds an endorsement issued pursuant to NRS 450B.1975, under the direct

supervision of a local health officer or a designee of the local health officer

pursuant to that section.

      8.  A respiratory therapist employed in a

health care facility. The therapist may possess and administer respiratory

products only at the direction of a physician.

      9.  A dialysis technician, under the

direction or supervision of a physician or registered nurse only if the drug or

medicine is used for the process of renal dialysis.

      10.  A medical student or student nurse in

the course of his or her studies at an approved college of medicine or school

of professional or practical nursing, at the direction of a physician and:

      (a) In the presence of a physician or a

registered nurse; or

      (b) Under the supervision of a physician or a

registered nurse if the student is authorized by the college or school to

administer the drug or medicine outside the presence of a physician or nurse.

Ê A medical

student or student nurse may administer a dangerous drug in the presence or

under the supervision of a registered nurse alone only if the circumstances are

such that the registered nurse would be authorized to administer it personally.

      11.  Any person designated by the head of a

correctional institution.

      12.  An ultimate user or any person

designated by the ultimate user pursuant to a written agreement.

      13.  A nuclear medicine technologist, at

the direction of a physician and in accordance with any conditions established

by regulation of the Board.

      14.  A radiologic technologist, at the

direction of a physician and in accordance with any conditions established by

regulation of the Board.

      15.  A chiropractic physician, but only if

the drug or medicine is a topical drug used for cooling and stretching external

tissue during therapeutic treatments.

      16.  A physical therapist, but only if the

drug or medicine is a topical drug which is:

      (a) Used for cooling and stretching external

tissue during therapeutic treatments; and

      (b) Prescribed by a licensed physician for:

             (1) Iontophoresis; or

             (2) The transmission of drugs through the

skin using ultrasound.

      17.  In accordance with applicable

regulations of the State Board of Health, an employee of a residential facility

for groups, as defined in NRS 449.017,

pursuant to a written agreement entered into by the ultimate user.

      18.  A veterinary technician or a

veterinary assistant at the direction of his or her supervising veterinarian.

      19.  In accordance with applicable

regulations of the Board, a registered pharmacist who:

      (a) Is trained in and certified to carry out

standards and practices for immunization programs;

      (b) Is authorized to administer immunizations

pursuant to written protocols from a physician; and

      (c) Administers immunizations in compliance with

the “Standards for Immunization Practices” recommended and approved by the

Advisory Committee on Immunization Practices of the Centers for Disease Control

and Prevention.

      20.  A registered pharmacist pursuant to

written guidelines and protocols developed and approved pursuant to NRS 639.2809.

      21.  A person who is enrolled in a training

program to become a physician assistant licensed pursuant to chapter 630 or 633

of NRS, dental hygienist, advanced emergency medical technician, paramedic,

respiratory therapist, dialysis technician, nuclear medicine technologist,

radiologic technologist, physical therapist or veterinary technician if the

person possesses and administers the drug or medicine in the same manner and

under the same conditions that apply, respectively, to a physician assistant

licensed pursuant to chapter 630 or 633 of NRS, dental hygienist, advanced emergency

medical technician, paramedic, respiratory therapist, dialysis technician,

nuclear medicine technologist, radiologic technologist, physical therapist or

veterinary technician who may possess and administer the drug or medicine, and

under the direct supervision of a person licensed or registered to perform the

respective medical art or a supervisor of such a person.

      22.  A medical assistant, in accordance

with applicable regulations of the:

      (a) Board of Medical Examiners, at the direction

of the prescribing physician and under the supervision of a physician or

physician assistant.

      (b) State Board of Osteopathic Medicine, at the

direction of the prescribing physician and under the supervision of a physician

or physician assistant.

      (Added to NRS by 1979, 1682; A 1981, 60, 746; 1983, 1221, 1515, 1937; 1987, 952, 1657, 2215; 1989, 749; 1991, 1956; 1993, 1216, 2839; 1995, 725, 1691; 1999, 2720; 2001, 2, 789, 792; 2003, 2296; 2005, 2476; 2007, 1866; 2009, 1534;

2011, 1341,

2609, 3080; 2013, 949, 2088)

      NRS 454.215  Authority to dispense dangerous drug.  A

dangerous drug may be dispensed by:

      1.  A registered pharmacist upon the legal

prescription from a practitioner or to a pharmacy in a correctional institution

upon the written order of the prescribing practitioner in charge;

      2.  A pharmacy in a correctional

institution, in case of emergency, upon a written order signed by the chief

medical officer;

      3.  A practitioner, or a physician

assistant licensed pursuant to chapter 630 or

633 of NRS if authorized by the Board;

      4.  A registered nurse, when the nurse is

engaged in the performance of any public health program approved by the Board;

      5.  A medical intern in the course of his

or her internship;

      6.  An advanced practice registered nurse

who holds a certificate from the State Board of Pharmacy permitting him or her

to dispense dangerous drugs;

      7.  A registered nurse employed at an institution

of the Department of Corrections to an offender in that institution;

      8.  A registered pharmacist from an

institutional pharmacy pursuant to regulations adopted by the Board; or

      9.  A registered nurse to a patient at a

rural clinic that is designated as such pursuant to NRS 433.233 and that is operated by the

Division of Public and Behavioral Health of the Department of Health and Human

Services if the nurse is providing mental health services at the rural clinic,

Ê except that

no person may dispense a dangerous drug in violation of a regulation adopted by

the Board.

      (Added to NRS by 1979, 1682; A 1981, 747; 1983, 1516; 1987, 807, 1583, 1658; 1989, 915; 1991, 794; 2001, 790; 2001

Special Session, 242; 2003, 1017; 2007, 1867; 2013, 2090)

      NRS 454.221  Furnishing dangerous drug without prescription prohibited;

penalty; exceptions.

      1.  A person who furnishes any dangerous

drug except upon the prescription of a practitioner is guilty of a category D

felony and shall be punished as provided in NRS

193.130, unless the dangerous drug was obtained originally by a legal

prescription.

      2.  The provisions of this section do not

apply to the furnishing of any dangerous drug by:

      (a) A practitioner to his or her patients;

      (b) A physician assistant licensed pursuant to chapter 630 or 633

of NRS if authorized by the Board;

      (c) A registered nurse while participating in a

public health program approved by the Board, or an advanced practice registered

nurse who holds a certificate from the State Board of Pharmacy permitting him

or her to dispense dangerous drugs;

      (d) A manufacturer or wholesaler or pharmacy to

each other or to a practitioner or to a laboratory under records of sales and

purchases that correctly give the date, the names and addresses of the supplier

and the buyer, the drug and its quantity;

      (e) A hospital pharmacy or a pharmacy so

designated by a county health officer in a county whose population is 100,000

or more, or by a district health officer in any county within its jurisdiction

or, in the absence of either, by the Chief Medical Officer or the Chief Medical

Officer’s designated Medical Director of Emergency Medical Services, to a

person or agency described in subsection 3 of NRS 639.268 to stock ambulances or other

authorized vehicles or replenish the stock; or

      (f) A pharmacy in a correctional institution to a

person designated by the Director of the Department of Corrections to

administer a lethal injection to a person who has been sentenced to death.

      (Added to NRS by 1973, 1197; A 1975, 354; 1977, 673, 938; 1979, 594, 1676; 1981, 747; 1983, 453, 1938; 1985, 887, 1701; 1987, 1658; 1989, 1126; 1991, 795; 1993, 451, 2841; 1995, 301, 1292, 1329; 2001, 791; 2001

Special Session, 242; 2007, 1868; 2013, 2091)

      NRS 454.223  Prescription to be written on prescription blank or chart of

patient; contents; regulations.

      1.  Except as otherwise provided in

subsection 4, each prescription for a dangerous drug must be written on a

prescription blank or as an order on the chart of a patient. A chart of a

patient may be used to order multiple prescriptions for that patient.

      2.  A written prescription must contain:

      (a) The name of the practitioner, the signature

of the practitioner if the prescription was not transmitted orally and the

address of the practitioner if not immediately available to the pharmacist;

      (b) The classification of his or her license;

      (c) The name of the patient, and the address of

the patient if not immediately available to the pharmacist;

      (d) The name, strength and quantity of the drug

or drugs prescribed;

      (e) The symptom or purpose for which the drug is

prescribed, if included by the practitioner pursuant to NRS 639.2352;

      (f) Directions for use; and

      (g) The date of issue.

      3.  Directions for use must be specific in

that they must indicate the portion of the body to which the medication is to

be applied, or, if to be taken into the body by means other than orally, the

orifice or canal of the body into which the medication is to be inserted or

injected.

      4.  The Board shall adopt regulations

concerning the electronic transmission of a prescription for a dangerous drug,

which must be consistent with federal law and the provisions of NRS 439.581 to 439.595, inclusive, and the regulations

adopted pursuant thereto.

      (Added to NRS by 1979, 1682; A 1981, 748; 1983, 1516; 1985, 887; 1987, 1659; 2007, 659; 2011, 1761)

      NRS 454.231  Pharmacist to fill or refill prescription for use only by person

to whom prescription originally issued.  No

pharmacist shall knowingly fill or refill any prescription for a dangerous drug

for use by any person other than the one for whom the prescription was originally

issued.

      (Added to NRS by 1973, 1197)

      NRS 454.286  Records: Maintenance; retention; inspection; penalty.

      1.  Every retail pharmacy, hospital or any

practitioner who engages in the practice of dispensing or furnishing drugs to

patients shall maintain a complete and accurate record of all dangerous drugs

purchased and those sold on prescription, dispensed, furnished or disposed of

otherwise.

      2.  The records must be retained for a

period of 2 years and must be open to inspection by members, inspectors or

investigators of the Board or inspectors of the Food and Drug Administration.

      3.  Invoices showing all purchases of

dangerous drugs constitute a complete record of all dangerous drugs received.

      4.  For the purpose of this section, the

prescription files of a pharmacy constitute a record of the disposition of all

dangerous drugs.

      5.  A person who violates any provision of

this section is guilty of a misdemeanor.

      (Added to NRS by 1973, 1198; A 1979, 1678; 1981, 748; 1987, 1034; 1989, 1000, 1126; 1991, 1165; 1995, 302)

      NRS 454.291  Stock of dangerous drugs and records open to inspection;

penalty.

      1.  All stock and records of purchase and

disposition of any dangerous drug of a wholesaler, pharmacy, practitioner,

hospital, laboratory or a nonprofit cooperative agriculture organization which

supplies and distributes drugs and medicines only to its members are at all

times, during business hours, open to inspection by agents, assistants, members

and inspectors of the Board, inspectors of the Food and Drug Administration,

and agents and commissioners appointed pursuant to chapter

585 of NRS for the enforcement of the Nevada Food, Drug and Cosmetic Act.

The records must be preserved for at least 2 years after the date of making.

      2.  Any person who fails, neglects or

refuses to maintain those records or who, when called upon by an authorized

officer to produce those records, fails, neglects or refuses to produce them,

or who willfully produces or furnishes records which are false, is guilty of a

misdemeanor.

      (Added to NRS by 1973, 1198; A 1979, 1678; 1981, 748; 1989, 1127; 1995, 302)

      NRS 454.296  Immunity from prosecution of employees of Board and peace

officers.  All agents, assistants

and inspectors of the Board and peace officers, while investigating violations

of NRS 454.181 to 454.371,

inclusive, in performance of their official duties, and any person working

under their immediate direction, supervision or instruction are immune from

prosecution under NRS 454.181 to 454.371, inclusive.

      (Added to NRS by 1973, 1198)

      NRS 454.301  Conditions under which practitioner or veterinarian may furnish

drugs without prescription.

      1.  Except as otherwise provided in

subsection 2, a practitioner who dispenses drugs and who personally furnishes

his or her own patients with such drugs as are necessary in the treatment of

the condition for which the practitioner attends a patient shall not do so

without writing a prescription unless the drugs so furnished are:

      (a) Not charged for, either separately or together

with charges for other professional services, and the practitioner keeps

accurate records, as required by NRS 454.286, of

all drugs so furnished;

      (b) Clearly labeled with the date, the name and

address of the furnisher, the name of the patient, the directions for use, the

name and strength and the expiration date of the effectiveness of the drug, if

that information is required on the original label of the manufacturer of that

drug; and

      (c) Not dispensed or furnished:

             (1) By a nurse or attendant; or

             (2) In violation of a regulation adopted

by the Board.

      2.  A veterinarian may furnish multiple

doses of drugs, necessary for the treatment of large animals, to ranchers or

dealers in livestock for use solely in the treatment of livestock on the

premises of the rancher or dealer, and when furnishing those drugs the

veterinarian is not required to comply with the provisions of subsection 1,

except for subparagraph (2) of paragraph (c).

      (Added to NRS by 1973, 1199; A 1979, 1678; 1981, 749; 1987, 807; 1989, 1127)

      NRS 454.303  Certain school employees authorized to administer

auto-injectable epinephrine.  A

school nurse or other employee of a public or private school who is authorized

pursuant to NRS 388.424 or 394.1995 to administer auto-injectable

epinephrine may possess and administer auto-injectable epinephrine maintained

by the school if the school nurse or other employee has received training in

the proper storage and administration of auto-injectable epinephrine as

required by NRS 388.424 or 394.1995.

      (Added to NRS by 2013, 1224)

      NRS 454.306  Use of minor as agent; unlawful furnishing of dangerous drug to

minor; penalty.  A person who

violates any provision of NRS 454.181 to 454.371, inclusive, by use of a minor as an agent or

by unlawfully furnishing any dangerous drug to a minor is guilty of a category

B felony and shall be punished by imprisonment in the state prison for a

minimum term of not less than 5 years and a maximum term of not more than 20

years, or by a fine of not more than $20,000, or by both fine and imprisonment.

      (Added to NRS by 1973, 1200; A 1979, 1475; 1995, 1292)

      NRS 454.311  Fraudulent possession of dangerous drug or prescription; false

or altered prescription; penalty.

      1.  A person, other than a peace officer or

inspector of the Board in the performance of his or her official duty, who

knowingly or intentionally obtains or attempts to obtain possession of a

dangerous drug or a prescription for a dangerous drug by misrepresentation,

fraud, forgery, deception, subterfuge or alteration is guilty of a category E

felony and shall be punished as provided in NRS

193.130.

      2.  A person who knowingly has in his or

her possession any false, fictitious, forged or altered prescription for a

dangerous drug is guilty of a category E felony and shall be punished as

provided in NRS 193.130.

      3.  A person who knowingly:

      (a) Receives any dangerous drug from, or has in

his or her possession or under his or her control any dangerous drug obtained

by, another person as a result of any forged, false, fictitious or altered

prescription; or

      (b) Fills a prescription which is not genuine,

Ê is guilty of

a category E felony and shall be punished as provided in NRS 193.130.

      (Added to NRS by 1973, 1200; A 1981, 1967; 1985, 153, 888; 1995, 1292)

      NRS 454.316  Possession of dangerous drug without prescription unlawful;

penalties; exceptions.

      1.  Except as otherwise provided in this

section, a person who possesses a dangerous drug, except that furnished to the

person by a pharmacist pursuant to a legal prescription or by a practitioner,

is guilty of a gross misdemeanor. A person who has been twice previously

convicted of any offense:

      (a) Described in this section; or

      (b) Pursuant to any other law of the United

States or this or any other state or district which if committed in this State

would have been punishable as an offense under this section,

Ê is guilty of

a category E felony and shall be punished as provided in NRS 193.130.

      2.  A prescription is not required for

possession of a dangerous drug by a person authorized by NRS

454.213, any other person or class of persons approved by the Board

pursuant to regulation, jobbers, wholesalers, manufacturers or laboratories

authorized by laws of this State to handle, possess and deal in dangerous drugs

if the drugs are in stock containers properly labeled and have been procured

from a manufacturer, wholesaler or pharmacy, or by a rancher who possesses a

dangerous drug in a reasonable amount for use solely in the treatment of

livestock on his or her own premises.

      (Added to NRS by 1973, 1200; A 1979, 953, 1679; 1987, 2216; 1991, 795, 1958; 1995, 1035, 1293, 1340)

      NRS 454.321  Unlawful dispensing or furnishing of dangerous drug; penalty.  Any person who dispenses or furnishes or permits

the dispensing or furnishing of any dangerous drug in violation of NRS 454.301 is guilty of a gross misdemeanor.

      (Added to NRS by 1973, 1200; A 1985, 889)

      NRS 454.323  Sale or distribution of product containing toluene to person

less than 18 years of age.

      1.  Except as provided in subsection 3, any

person who sells or gives aerosol paint, glue or cement containing toluene to a

person who is less than 18 years of age is guilty of a gross misdemeanor.

      2.  The court shall suspend for a period of

1 year the business license of a person who knowingly violates any provision of

this section after having been previously convicted of a violation of this

section unless the person can demonstrate that he or she attempted in good

faith to comply with this section.

      3.  The provisions of this section do not

apply to the sale of:

      (a) Gasoline or other fuel for motor vehicles;

      (b) Aerosol paint, glue or cement containing less

than the minimum amount of toluene which is subject to the requirements for

special labeling established pursuant to the Federal Hazardous Substances Act,

15 U.S.C. §§ 1261 et seq., as it exists on June 30, 1983; or

      (c) Glue or cement which is included in a kit

used for the construction of model airplanes, automobiles, boats or trains or

which is used in connection with another hobby.

      (Added to NRS by 1983, 242)

      NRS 454.326  Misrepresentation by use of telephone to obtain dangerous drug;

penalty.  A person who, in order to

obtain any dangerous drug, falsely represents himself or herself in a telephone

conversation with a pharmacist to be a physician or other person who can

lawfully prescribe such drugs or to be acting on behalf of a person who can

lawfully prescribe drugs:

      1.  For the first offense, is guilty of a

misdemeanor.

      2.  For any subsequent offense, is guilty

of a category E felony and shall be punished as provided in NRS 193.130.

      (Added to NRS by 1973, 1201; A 1979, 1476; 1995, 1293)

      NRS 454.341  Unlawful possession or sale of nasal inhaler; exception.  It is unlawful for any person within this

State to possess, sell, offer to sell or hold for the purpose of sale or resale

any nasal inhaler which contains any drug capable of causing stimulation to the

central nervous system unless:

      1.  The product contains a denaturant in

sufficient quantity to render it unfit for internal use; and

      2.  The product is among such products

listed as approved for sale without restriction by the Board in the regulations

officially adopted by the Board.

      (Added to NRS by 1973, 1201)

      NRS 454.346  Use or possession with intent to use drug, chemical, poison or

organic solvent to induce euphoria or hallucinations unlawful; exception.

      1.  Any person who inhales, ingests,

applies or otherwise uses or possesses with the intent to inhale, ingest, apply

or otherwise use any drug, chemical, poison or organic solvent, or any compound

or combination of any drug, chemical, poison or organic solvent, in any manner

contrary to the directions for use, cautions or warnings appearing on the label

thereof, in order to create or induce a condition of intoxication, euphoria,

hallucination or elation, or to change, distort or disturb his or her eyesight,

thinking processes, balance or coordination or to affect his or her central

nervous system is guilty of a misdemeanor.

      2.  The provisions of this section do not

apply to a person who uses or intends to use any drug, chemical, poison or

organic solvent for medicinal purposes under the supervision of a physician,

when the drug, chemical, poison or organic solvent is used or intended for use

in keeping with the directions for use as given by the physician.

      (Added to NRS by 1973, 75; A 1983, 242)

      NRS 454.351  Drugs which may not be introduced into interstate commerce;

penalty; exemptions.

      1.  Any person within this State who

possesses, procures, obtains, processes, produces, derives, manufactures,

sells, offers for sale, gives away or otherwise furnishes any drug which may

not be lawfully introduced into interstate commerce under the Federal Food,

Drug and Cosmetic Act is guilty of a misdemeanor.

      2.  The provisions of this section do not

apply:

      (a) To physicians licensed to practice in this

State who have been authorized by the Food and Drug Administration to possess

experimental drugs for the purpose of conducting research to evaluate the

effectiveness of such drugs and who maintain complete and accurate records of

the use of such drugs and submit clinical reports as required by the Food and

Drug Administration.

      (b) To any substance which has been licensed by

the State Board of Health for manufacture in this State but has not been

approved as a drug by the Food and Drug Administration. The exemption granted

in this paragraph does not grant authority to transport such a substance out of

this State.

      (Added to NRS by 1973, 1201; A 1981, 749)

      NRS 454.356  Penalty for violation.  Except

as otherwise specifically provided, every person who violates any provision of NRS 454.181 to 454.371,

inclusive, is guilty of a misdemeanor.

      (Added to NRS by 1973, 1201)

      NRS 454.358  Fee for analysis of dangerous drug included in sentence;

distribution of money collected; limitations on use of money.

      1.  When a defendant pleads guilty or

guilty but mentally ill to, or is found guilty or guilty but mentally ill of,

any violation of this chapter and an analysis of a dangerous drug was performed

in relation to the defendant’s case, the justice or judge shall include in the

sentence the sum of $50 as a fee for the analysis of the dangerous drug.

      2.  The money collected for such an

analysis must not be deducted from the fine imposed by the justice or judge,

but must be taxed against the defendant in addition to the fine. The money

collected for such an analysis must be stated separately on the court’s docket

and must be included in the amount posted for bail. If the defendant is found

not guilty or the charges are dropped, the money deposited with the court must

be returned to the defendant.

      3.  The money collected pursuant to

subsection 1 in municipal court must be paid by the clerk of the court to the

county treasurer on or before the fifth day of each month for the preceding

month.

      4.  The money collected pursuant to

subsection 1 in justice courts must be paid by the clerk of the court to the

county treasurer on or before the fifth day of each month for the preceding

month.

      5.  The board of county commissioners of

each county shall by ordinance, before September 1, 1987, create in the county

treasury a fund to be designated as the fund for forensic services. Upon

receipt, the county treasurer shall deposit any fee for the analyses of

dangerous drugs in the fund.

      6.  In counties which receive forensic

services under a contract with the State, any money in the fund for forensic

services must be paid monthly by the county treasurer to the State Treasurer

for deposit in the State General Fund, after retaining 2 percent of the money

to cover his or her administrative expenses.

      7.  In counties which do not receive

forensic services under a contract with the State, money in the fund for

forensic services must be expended, except as otherwise provided in this

subsection:

      (a) To pay for the analyses of dangerous drugs

performed in connection with criminal investigations within the county;

      (b) To purchase and maintain equipment to conduct

these analyses; and

      (c) For the training and continuing education of

the employees who conduct these analyses.

Ê Money from

the fund must not be expended to cover the costs of analyses conducted by,

equipment used by or training for employees of an analytical laboratory not

registered with the Drug Enforcement Administration of the United States

Department of Justice.

      (Added to NRS by 1987, 1398; A 1995, 2469; 2003, 1488; 2007, 1448)

      NRS 454.361  Conviction for violation of provision concerning dangerous drugs

constitutes grounds for suspension or revocation of professional license.  A conviction of the violation of any of the

provisions of NRS 454.181 to 454.371,

inclusive, constitutes grounds for the suspension or revocation of any license

issued to such person pursuant to the provisions of chapters 630, 631,

633, 635, 636, 638 or 639 of NRS.

      (Added to NRS by 1973, 1201; A 1995, 1035)

      NRS 454.366  Administration and enforcement by Board.  The Board shall administer and enforce NRS 454.181 to 454.371,

inclusive.

      (Added to NRS by 1973, 1201)

      NRS 454.371  Limitations on furnishing dangerous drug; adoption of

regulations by Board; penalties.

      1.  If the Board finds any drug to be

dangerous to the public health or safety, it may adopt a regulation not

inconsistent with NRS 454.181 to 454.371, inclusive, limiting or restricting the

furnishing or dispensing of the drug.

      2.  A violation of such a regulation must

be punished in the same manner as provided in NRS

454.306 to 454.356, inclusive.

      (Added to NRS by 1973, 1201; A 1977, 74; 1987, 807)

Hypodermic Devices

      NRS 454.480  Requirements for sale with or without prescription.

      1.  Hypodermic devices which are not

restricted by federal law to sale by or on the order of a physician may be sold

by a pharmacist, or by a person in a pharmacy under the direction of a

pharmacist, on the prescription of a physician, dentist or veterinarian, or of

an advanced practice registered nurse who is a practitioner. Those

prescriptions must be filed as required by NRS

639.236, and may be refilled as authorized by the prescriber. Records of

refilling must be maintained as required by NRS

639.2393 to 639.2397, inclusive.

      2.  Hypodermic devices which are not restricted

by federal law to sale by or on the order of a physician may be sold or

furnished without a prescription.

      (Added to NRS by 1967, 1639; A 1971, 2028; 1973,

1202; 1983, 454,

1221; 1985, 1702; 1991, 796; 1993, 1223; 1995, 302; 2013, 2091,

3176)

      NRS 454.500  Regulation of sale of hypodermic devices other than hypodermic

needles or syringes.  The Board

shall establish, by regulation, the type of devices other than hypodermic

needles and syringes that must be sold in compliance with the provisions of NRS 454.480 to 454.530,

inclusive.

      (Added to NRS by 1967, 1640; A 1977, 74; 1993, 1224)

      NRS 454.510  Unlawful possession of hypodermic device.  It is unlawful for any person to have in his

or her possession or under his or her control any hypodermic device unless the

person has acquired possession of such device in accordance with the provisions

of NRS 454.480 to 454.530,

inclusive.

      (Added to NRS by 1967, 1640; A 1993, 1224)

      NRS 454.520  Misuse of hypodermic device; penalty.  Repealed.

(See chapter 497, Statutes of Nevada 2013, at page 3176.)

 

      NRS 454.530  Obtaining possession of hypodermic device by forged or

fictitious name or fraudulent misrepresentation; penalty.  Any person who obtains possession of any

hypodermic device by a fraudulent representation, a forged or fictitious name,

or in violation of the provisions of NRS 454.480 to

454.530, inclusive, is guilty of a gross

misdemeanor.

      (Added to NRS by 1967, 1640; A 1981, 1967; 1993, 1224)

Enforcement

      NRS 454.534  Burden of proving exception or exemption.  In any complaint, information or indictment

and in any action or proceeding brought for the enforcement of any provision of

NRS 454.181 to 454.530,

inclusive, it is not necessary to negate any exception, excuse, proviso or

exemption contained in NRS 454.181 to 454.530, inclusive, and the burden of proof of any

such exception, excuse, proviso or exemption is upon the defendant.

      (Added to NRS by 1969, 283; A 1971, 2029; 1973, 1202;

1983, 243)

      NRS 454.535  Amount of drug needed to sustain conviction for prohibited

offense.  The amount of a drug

needed to sustain a conviction of a person for an offense prohibited by NRS 454.181 to 454.371,

inclusive, is that amount necessary for identification as such drug by a

witness qualified to make such identification for the prosecution and a witness

qualified to make such identification for the defense.

      (Added to NRS by 1971, 359; A 1973, 1202)

MISCELLANEOUS PROVISIONS

      NRS 454.680  Applicability to certain products.  This

chapter does not apply to:

      1.  Except as otherwise provided in NRS 454.323, products subject to the provisions of the

Federal Hazardous Substances Act, 15 U.S.C. §§ 1261 et seq.; and

      2.  Products registered under the Federal

Insecticide, Fungicide, and Rodenticide Act, 7 U.S.C. §§ 136 et seq.,

Ê as the acts

exist, respectively, on June 30, 1983.

      (Added to NRS by 1967, 1631; A 1983, 243)

      NRS 454.695  Prescriptions by advanced practice registered nurses.  An advanced practice registered nurse may

prescribe poisons, dangerous drugs and devices for legitimate medical purposes

in accordance with the certificate he or she holds from the Board and the

license issued by the State Board of Nursing.

      (Added to NRS by 1983, 1220; A 1991, 797; 2013, 2092)

      NRS 454.710  Injunctions.  The

Board may bring an action to enjoin any act which would be in violation of the

provisions of this chapter. Such action must be commenced in the district court

for the county in which the act is to occur and must be in conformity with Rule 65 of the Nevada Rules of

Civil Procedure, except that the Board is not required to allege facts

necessary to show or tending to show lack of adequate remedy at law or

irreparable damage or loss. The action must be brought in the name of the State

of Nevada.

      (Added to NRS by 1979, 1681)